董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Donald M. Berwick | 男 | Director | 79 | 25.00万美元 | 7.43 | 2026-04-28 |
| Stephen H. Lockhart | 男 | Director | 67 | 17.50万美元 | 5.33 | 2026-04-28 |
| Penny A. Wheeler | 女 | Director | 67 | 25.00万美元 | 6.71 | 2026-04-28 |
| Parul Bhandari | 女 | Director | 50 | 17.50万美元 | 5.13 | 2026-04-28 |
| Trent Green | 男 | Chief Executive Officer and Director | 54 | 1196.19万美元 | 50.00 | 2026-04-28 |
| Michael D. Hays | 男 | Chair and Director | 71 | 18.44万美元 | 84.73 | 2026-04-28 |
| John N. Nunnelly | 男 | Director | 73 | 27.50万美元 | 11.05 | 2026-04-28 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Helen L. Hrdy | 女 | Chief Operating Officer and Executive Vice President | 61 | 247.48万美元 | 18.03 | 2026-04-28 |
| Andrew Monnich | 男 | Chief Corporate Development Officer and Executive Vice President | 50 | 247.48万美元 | 10.00 | 2026-04-28 |
| Jordan N. Freeman | 女 | Chief Accounting Officer | 38 | 未披露 | 未持股 | 2026-04-28 |
| Shane Harrison | 男 | Chief Financial Officer and Executive Vice President | 49 | 248.11万美元 | 15.87 | 2026-04-28 |
| Trent Green | 男 | Chief Executive Officer and Director | 54 | 1196.19万美元 | 50.00 | 2026-04-28 |
| David Burik | 男 | Executive Vice President, Strategic Insights | 68 | 未披露 | 未持股 | 2026-04-28 |
| Jason R. Rau | 男 | Executive Vice President, Sales | 55 | 61.91万美元 | 未持股 | 2026-04-28 |
董事简历
中英对照 | 中文 | 英文- Donald M. Berwick
-
Donald M. Berwick，自2015年10月起担任公司董事。Berwick博士是医疗保健改善研究所的前任总裁兼首席执行官，他与人共同创立并领导了该研究所近20年，他现在担任该研究所的名誉总裁和高级研究员。他目前也是哈佛医学院卫生保健政策系的讲师。2010年7月至2011年12月，Berwick博士作为美国总统奥巴马的任命者，担任医疗保险和医疗补助服务中心的管理员。Berwick博士此前曾任职于哈佛医学院和哈佛公共卫生学院（1974年至2010年）。他还曾担任美国预防服务工作队副主席（1990年至1995年）、美国医院协会董事会首位“独立成员”（1996年至1999年）和医疗保健研究和质量机构国家咨询委员会主席（1995年至1999年）。
Donald M. Berwick has served as a director of the Company since October 2015. Dr. Berwick is the former President and Chief Executive Officer of the Institute for Healthcare Improvement, a nonprofit focused on improving healthcare worldwide, which he co founded and led for almost 20 years, and where he now serves as President Emeritus. He has also been a Lecturer in the Department of Health Care Policy at Harvard Medical School. In 2026, Dr. Berwick joined the Board of Directors of BMC Hospitals Group, a consortium of Boston's safety net hospitals. From July 2010 to December 2011, Dr. Berwick served as the Administrator of the Centers for Medicare and Medicaid Services as an appointee of President Barack Obama. Dr. Berwick previously served on the faculty of the Harvard Medical School and the Harvard School of Public Health (from 1974 to 2010). He was also vice chair of the U.S. Preventive Services Task Force (from 1990 to 1995), the first "Independent Member" of the Board of Trustees of the American Hospital Association (from 1996 to 1999) and the chair of the National Advisory Council of the Agency for Healthcare Research and Quality (from 1995 to 1999). - Donald M. Berwick，自2015年10月起担任公司董事。Berwick博士是医疗保健改善研究所的前任总裁兼首席执行官，他与人共同创立并领导了该研究所近20年，他现在担任该研究所的名誉总裁和高级研究员。他目前也是哈佛医学院卫生保健政策系的讲师。2010年7月至2011年12月，Berwick博士作为美国总统奥巴马的任命者，担任医疗保险和医疗补助服务中心的管理员。Berwick博士此前曾任职于哈佛医学院和哈佛公共卫生学院（1974年至2010年）。他还曾担任美国预防服务工作队副主席（1990年至1995年）、美国医院协会董事会首位“独立成员”（1996年至1999年）和医疗保健研究和质量机构国家咨询委员会主席（1995年至1999年）。
- Donald M. Berwick has served as a director of the Company since October 2015. Dr. Berwick is the former President and Chief Executive Officer of the Institute for Healthcare Improvement, a nonprofit focused on improving healthcare worldwide, which he co founded and led for almost 20 years, and where he now serves as President Emeritus. He has also been a Lecturer in the Department of Health Care Policy at Harvard Medical School. In 2026, Dr. Berwick joined the Board of Directors of BMC Hospitals Group, a consortium of Boston's safety net hospitals. From July 2010 to December 2011, Dr. Berwick served as the Administrator of the Centers for Medicare and Medicaid Services as an appointee of President Barack Obama. Dr. Berwick previously served on the faculty of the Harvard Medical School and the Harvard School of Public Health (from 1974 to 2010). He was also vice chair of the U.S. Preventive Services Task Force (from 1990 to 1995), the first "Independent Member" of the Board of Trustees of the American Hospital Association (from 1996 to 1999) and the chair of the National Advisory Council of the Agency for Healthcare Research and Quality (from 1995 to 1999).
- Stephen H. Lockhart
-
Stephen H. Lockhart，自2021年5月起担任National Research Corporation的董事。他曾担任Sutter Health Network的高级副总裁兼首席医疗官（从2015年到2021年），这是一个由北加州的医院、医生组织和研究机构组成的非营利系统。在此之前，他曾担任Sutter Health Network的东湾区域首席医疗官（2010年至2015年）。从2008年到2010年，Lockhart博士担任萨特加州太平洋医疗中心圣卢克校区的首席行政官。2017年，Lockhart博士被任命为加州州长布朗的精准医疗咨询委员会成员，这是加州使用先进计算和技术更好地理解、治疗和预防疾病的努力的一部分。他是Molina Healthcare, Inc.的董事会成员。纽约证券交易所：MOH，医疗补助和医疗保险计划和州保险市场的健康计划提供者。Lockhart博士还任职于ECRI Institute, entertainment Equipment, Inc.，the David and Lucile Packard Foundation，以及Parks California（致力于支持加州公园和公共土地的非营利组织）的董事会。1984/1985年获得康奈尔大学医学博士和博士学位。
Stephen H. Lockhart has served as a director of the Company since May 2021. Dr. Lockhart served as senior vice president and chief medical officer for Sutter Health Network, a not for profit system of hospitals, physician organizations, and research institutions in Northern California, from 2015 to 2021. Prior to that role, Dr. Lockhart served as Sutter Health Network's regional chief medical officer for the East Bay Region from 2010 to 2015. From 2008 to 2010, Dr. Lockhart served as the chief administrative officer at the St. Luke's campus of Sutter's California Pacific Medical Center. In 2017, Dr. Lockhart was named to California Governor Brown's Advisory Committee on Precision Medicine as part of California's effort to use advanced computing and technology to better understand, treat, and prevent disease. Dr. Lockhart serves on the boards of Molina Healthcare, Inc. (NYSE: MOH), a health plan provider under Medicaid and Medicare programs and in state insurance marketplaces, and West Pharmaceutical Services, Inc. (NYSE: WST), a leading global manufacturer of integrated containment and delivery systems for injectable medicines. Dr. Lockhart also serves on the board of the David and Lucile Packard Foundation and is chairman of Parks California – a nonprofit dedicated to supporting California's parks and public lands. Dr. Lockhart's 36 years of experience in the healthcare industry and his background as medical provider and administrator in a large healthcare system led to the conclusion that he should serve as a director of the Company. - Stephen H. Lockhart，自2021年5月起担任National Research Corporation的董事。他曾担任Sutter Health Network的高级副总裁兼首席医疗官（从2015年到2021年），这是一个由北加州的医院、医生组织和研究机构组成的非营利系统。在此之前，他曾担任Sutter Health Network的东湾区域首席医疗官（2010年至2015年）。从2008年到2010年，Lockhart博士担任萨特加州太平洋医疗中心圣卢克校区的首席行政官。2017年，Lockhart博士被任命为加州州长布朗的精准医疗咨询委员会成员，这是加州使用先进计算和技术更好地理解、治疗和预防疾病的努力的一部分。他是Molina Healthcare, Inc.的董事会成员。纽约证券交易所：MOH，医疗补助和医疗保险计划和州保险市场的健康计划提供者。Lockhart博士还任职于ECRI Institute, entertainment Equipment, Inc.，the David and Lucile Packard Foundation，以及Parks California（致力于支持加州公园和公共土地的非营利组织）的董事会。1984/1985年获得康奈尔大学医学博士和博士学位。
- Stephen H. Lockhart has served as a director of the Company since May 2021. Dr. Lockhart served as senior vice president and chief medical officer for Sutter Health Network, a not for profit system of hospitals, physician organizations, and research institutions in Northern California, from 2015 to 2021. Prior to that role, Dr. Lockhart served as Sutter Health Network's regional chief medical officer for the East Bay Region from 2010 to 2015. From 2008 to 2010, Dr. Lockhart served as the chief administrative officer at the St. Luke's campus of Sutter's California Pacific Medical Center. In 2017, Dr. Lockhart was named to California Governor Brown's Advisory Committee on Precision Medicine as part of California's effort to use advanced computing and technology to better understand, treat, and prevent disease. Dr. Lockhart serves on the boards of Molina Healthcare, Inc. (NYSE: MOH), a health plan provider under Medicaid and Medicare programs and in state insurance marketplaces, and West Pharmaceutical Services, Inc. (NYSE: WST), a leading global manufacturer of integrated containment and delivery systems for injectable medicines. Dr. Lockhart also serves on the board of the David and Lucile Packard Foundation and is chairman of Parks California – a nonprofit dedicated to supporting California's parks and public lands. Dr. Lockhart's 36 years of experience in the healthcare industry and his background as medical provider and administrator in a large healthcare system led to the conclusion that he should serve as a director of the Company.
- Penny A. Wheeler
-
Penny A. Wheeler，自2021年5月起担任National Research Corporation的董事。自2015年以来，Wheeler博士担任Allina Health的首席执行官，这是一个非营利性医疗保健系统，为Minnesota 和western Wisconsin的150多万人提供服务。在此之前，她曾担任首席临床官（2006年以来）。20年来，Wheeler博士还担任委员会认证的产科医生/妇科医生，在那里她花了大量的时间与患者和社区进行互动和护理。2015年，Minnesota Governor Mark Dayton任命Wheeler博士为卫生保健融资工作组成员，Wheeler博士被《现代医疗》杂志评为卫生保健领域最优秀的25位女性之一。Wheeler博士还担任Portico Healthnet董事会成员，这是一个非营利组织，致力于帮助没有保险的Minnesota人获得可负担的健康保险和保健，圣托马斯大学和Minnesota 大学基金会。她也是Cedar Cares的董事会成员，该组织通过定制化的参与来简化患者的计费体验。
Penny A. Wheeler has served as a director of the Company since May 2021. From 2015 to 2021, Dr. Wheeler served as the chief executive officer of Allina Health, a not for profit healthcare system serving over 1.5 million individuals in Minnesota and western Wisconsin. Prior to that role she served as chief clinical officer since 2006. For 20 years, Dr. Wheeler has also served as a board certified obstetrician/gynecologist where she spent considerable time interacting with, and caring for, patients and the community. In 2015, Minnesota Governor Mark Dayton appointed Dr. Wheeler to the Taskforce for Health Care Financing, and Dr. Wheeler has been named as one of the top 25 women in healthcare by Modern Healthcare magazine. Dr. Wheeler currently serves as a Regent of the University of Minnesota. She is a past chair of the University's Academic Health Committee and currently chairs the Finance Committee of the Board of Regents. She is also on the Board of Cedar Cares, an organization that eases the patient billing experience through customized engagement. Dr. Wheeler's past leadership experiences in the healthcare industry led to the conclusion that she should serve as a director of the Company. - Penny A. Wheeler，自2021年5月起担任National Research Corporation的董事。自2015年以来，Wheeler博士担任Allina Health的首席执行官，这是一个非营利性医疗保健系统，为Minnesota 和western Wisconsin的150多万人提供服务。在此之前，她曾担任首席临床官（2006年以来）。20年来，Wheeler博士还担任委员会认证的产科医生/妇科医生，在那里她花了大量的时间与患者和社区进行互动和护理。2015年，Minnesota Governor Mark Dayton任命Wheeler博士为卫生保健融资工作组成员，Wheeler博士被《现代医疗》杂志评为卫生保健领域最优秀的25位女性之一。Wheeler博士还担任Portico Healthnet董事会成员，这是一个非营利组织，致力于帮助没有保险的Minnesota人获得可负担的健康保险和保健，圣托马斯大学和Minnesota 大学基金会。她也是Cedar Cares的董事会成员，该组织通过定制化的参与来简化患者的计费体验。
- Penny A. Wheeler has served as a director of the Company since May 2021. From 2015 to 2021, Dr. Wheeler served as the chief executive officer of Allina Health, a not for profit healthcare system serving over 1.5 million individuals in Minnesota and western Wisconsin. Prior to that role she served as chief clinical officer since 2006. For 20 years, Dr. Wheeler has also served as a board certified obstetrician/gynecologist where she spent considerable time interacting with, and caring for, patients and the community. In 2015, Minnesota Governor Mark Dayton appointed Dr. Wheeler to the Taskforce for Health Care Financing, and Dr. Wheeler has been named as one of the top 25 women in healthcare by Modern Healthcare magazine. Dr. Wheeler currently serves as a Regent of the University of Minnesota. She is a past chair of the University's Academic Health Committee and currently chairs the Finance Committee of the Board of Regents. She is also on the Board of Cedar Cares, an organization that eases the patient billing experience through customized engagement. Dr. Wheeler's past leadership experiences in the healthcare industry led to the conclusion that she should serve as a director of the Company.
- Parul Bhandari
-
Parul Bhandari目前领导微软全球媒体和通信行业解决方案团队的合作伙伴战略。班达里女士还领导了全球公共部门的数据和人工智能，推动跨行业合作伙伴关系，并参与全球数字转型计划。任职Microsoft公司之前，她曾担任Acelsior公司的业务开发和联盟副总裁。
Parul Bhandari has served as a director of the Company since May 2022. Ms. Bhandari has more than 20 years of experience driving growth and innovation at the world's leading technology and business development companies. Since 2012, she has held various leadership roles at Microsoft Corporation, a global technology company (NASDAQ: MSFT). Currently, Ms. Bhandari is the Director, Partner Strategy, Worldwide Telco, Media & Gaming at Microsoft, where she contributes to global partner recruiting, enablement and engagement. Previously, Ms. Bhandari was focused on leading Data and Machine Learning for Microsoft's Worldwide Public Sector. Prior to joining Microsoft, Ms. Bhandari served as Vice President of Business Development and Alliances for the management consulting firm Acelsior, teaming with large defense contractors. Ms. Bhandari has served as a director of Timberland Bancorp, Inc. (NASDAQ: TSBK) since 2021. Ms. Bhandari also served as a director of Cartica Acquisition Corp (NASDAQ: CITE), a blank check company, from January 2022 to May 2023. - Parul Bhandari目前领导微软全球媒体和通信行业解决方案团队的合作伙伴战略。班达里女士还领导了全球公共部门的数据和人工智能，推动跨行业合作伙伴关系，并参与全球数字转型计划。任职Microsoft公司之前，她曾担任Acelsior公司的业务开发和联盟副总裁。
- Parul Bhandari has served as a director of the Company since May 2022. Ms. Bhandari has more than 20 years of experience driving growth and innovation at the world's leading technology and business development companies. Since 2012, she has held various leadership roles at Microsoft Corporation, a global technology company (NASDAQ: MSFT). Currently, Ms. Bhandari is the Director, Partner Strategy, Worldwide Telco, Media & Gaming at Microsoft, where she contributes to global partner recruiting, enablement and engagement. Previously, Ms. Bhandari was focused on leading Data and Machine Learning for Microsoft's Worldwide Public Sector. Prior to joining Microsoft, Ms. Bhandari served as Vice President of Business Development and Alliances for the management consulting firm Acelsior, teaming with large defense contractors. Ms. Bhandari has served as a director of Timberland Bancorp, Inc. (NASDAQ: TSBK) since 2021. Ms. Bhandari also served as a director of Cartica Acquisition Corp (NASDAQ: CITE), a blank check company, from January 2022 to May 2023.
- Trent Green
-
特伦特·格林自2025年6月起担任NRC Health的首席执行官。在加入公司之前，Green先生于2023年9月至2025年2月期间担任亚马逊旗下混合初级保健提供商Amazon One Medical的首席执行官，并于2022年7月至2023年8月期间担任Amazon One Medical的首席运营官。在加入Amazon One Medical之前，格林先生曾在非营利性医疗保健系统Legacy Health担任多个职务，包括2019年至2022年期间的高级副总裁兼首席运营官，2017年至2019年期间的伊曼纽尔医疗中心总裁，以及2008年至2017年期间的高级副总裁兼首席战略官。1999年至2008年，Green先生是Tiber Group/法维翰咨询（现为Guidehouse）的管理顾问。
Trent Green has served as Nrc Health's Chief Executive Officer since June 2025. Prior to joining the Company, Mr. Green served as Chief Executive Officer of Amazon One Medical, a hybrid primary care provider owned by Amazon, from September 2023 to February 2025 and as Chief Operating Officer of Amazon One Medical from July 2022 through August 2023. Prior to Amazon One Medical, Mr. Green served in various roles at Legacy Health, a nonprofit healthcare system, including Senior Vice President and Chief Operating Officer between 2019 and 2022, President, Emanuel Medical Center, between 2017 and 2019, and Senior Vice President and Chief Strategy Officer between 2008 and 2017. From 1999 to 2008, Mr. Green was a management consultant for Tiber Group/Navigant Consulting (now Guidehouse). - 特伦特·格林自2025年6月起担任NRC Health的首席执行官。在加入公司之前，Green先生于2023年9月至2025年2月期间担任亚马逊旗下混合初级保健提供商Amazon One Medical的首席执行官，并于2022年7月至2023年8月期间担任Amazon One Medical的首席运营官。在加入Amazon One Medical之前，格林先生曾在非营利性医疗保健系统Legacy Health担任多个职务，包括2019年至2022年期间的高级副总裁兼首席运营官，2017年至2019年期间的伊曼纽尔医疗中心总裁，以及2008年至2017年期间的高级副总裁兼首席战略官。1999年至2008年，Green先生是Tiber Group/法维翰咨询（现为Guidehouse）的管理顾问。
- Trent Green has served as Nrc Health's Chief Executive Officer since June 2025. Prior to joining the Company, Mr. Green served as Chief Executive Officer of Amazon One Medical, a hybrid primary care provider owned by Amazon, from September 2023 to February 2025 and as Chief Operating Officer of Amazon One Medical from July 2022 through August 2023. Prior to Amazon One Medical, Mr. Green served in various roles at Legacy Health, a nonprofit healthcare system, including Senior Vice President and Chief Operating Officer between 2019 and 2022, President, Emanuel Medical Center, between 2017 and 2019, and Senior Vice President and Chief Strategy Officer between 2008 and 2017. From 1999 to 2008, Mr. Green was a management consultant for Tiber Group/Navigant Consulting (now Guidehouse).
- Michael D. Hays
-
Michael D. Hays自1981年他创建公司担任首席执行官以及董事。他还从1981年到2004年以及从2008年7月都2011年7月担任公司的总裁。在创建公司前，Hays在SRI Research Center, Inc. n/k/a the Gallup Organization担任了7年到的副总裁以及董事。
Michael D. Hays has served as a director since he founded the Company in 1981 and as Chair since June 2025. He also served as President of the Company from 1981 to 2004, from July 2008 to July 2011, and from October 2020 to May 2025, and as Chief Executive Officer from 1981 to May 2025. Prior to founding the Company, Mr. Hays served for seven years as a Vice President and a director of SRI Research Center, Inc. (n/k/a the Gallup Organization). Mr. Hays' background as founder of the Company, and his long and successful tenure as Chief Executive Officer and a director, led to the conclusion that he should serve as a director of the Company. - Michael D. Hays自1981年他创建公司担任首席执行官以及董事。他还从1981年到2004年以及从2008年7月都2011年7月担任公司的总裁。在创建公司前，Hays在SRI Research Center, Inc. n/k/a the Gallup Organization担任了7年到的副总裁以及董事。
- Michael D. Hays has served as a director since he founded the Company in 1981 and as Chair since June 2025. He also served as President of the Company from 1981 to 2004, from July 2008 to July 2011, and from October 2020 to May 2025, and as Chief Executive Officer from 1981 to May 2025. Prior to founding the Company, Mr. Hays served for seven years as a Vice President and a director of SRI Research Center, Inc. (n/k/a the Gallup Organization). Mr. Hays' background as founder of the Company, and his long and successful tenure as Chief Executive Officer and a director, led to the conclusion that he should serve as a director of the Company.
- John N. Nunnelly
-
John N. Nunnelly自1997年12月担任董事。Nunnelly先生是McKesson Corporation已退休的集团总裁，该公司是药物分销和健康护理信息技术领域是主导公司。在McKesson 28年的任职经历中，Nunnelly先生担任过各种职务，包括策略规划和业务开发部门的副总裁；Amherst Product Group的副总裁以及总经理；以及Sales-Decision Support的副总裁。其职责包括领导一些业务单元，其中包括年收入3.6亿美元的一个业务单元。另外，他还管理一些并购业务。Nunnelly先生还是马赛诸塞大学护理学院（University of Massachusetts, School of Nursing）的兼职教授，对学生以及教职员工在健康保健信息技术相关领域提供指导。
John N. Nunnelly has served as a director of the Company since December 1997, and lead director since May 2012. Mr. Nunnelly is a retired Group President from McKesson Corporation, a leader in pharmaceutical distribution and healthcare information technology. During his 28 year career at McKesson, Mr. Nunnelly served in a variety of other positions, including Vice President of Strategic Planning and Business Development, Vice President and General Manager of the Amherst Product Group and Vice President of Sales Decision Support. These responsibilities included leading several business units, including one with over $360 million in annual revenue. In addition, he was involved in managing a number of mergers and acquisitions. Mr. Nunnelly has also served as an adjunct professor at the University of Massachusetts, School of Nursing, advising students and faculty on matters pertaining to healthcare information technology. These experiences and Mr. Nunnelly's expertise as a professional and educator in the field of healthcare information technology led to the conclusion that he should serve as a director of the Company. - John N. Nunnelly自1997年12月担任董事。Nunnelly先生是McKesson Corporation已退休的集团总裁，该公司是药物分销和健康护理信息技术领域是主导公司。在McKesson 28年的任职经历中，Nunnelly先生担任过各种职务，包括策略规划和业务开发部门的副总裁；Amherst Product Group的副总裁以及总经理；以及Sales-Decision Support的副总裁。其职责包括领导一些业务单元，其中包括年收入3.6亿美元的一个业务单元。另外，他还管理一些并购业务。Nunnelly先生还是马赛诸塞大学护理学院（University of Massachusetts, School of Nursing）的兼职教授，对学生以及教职员工在健康保健信息技术相关领域提供指导。
- John N. Nunnelly has served as a director of the Company since December 1997, and lead director since May 2012. Mr. Nunnelly is a retired Group President from McKesson Corporation, a leader in pharmaceutical distribution and healthcare information technology. During his 28 year career at McKesson, Mr. Nunnelly served in a variety of other positions, including Vice President of Strategic Planning and Business Development, Vice President and General Manager of the Amherst Product Group and Vice President of Sales Decision Support. These responsibilities included leading several business units, including one with over $360 million in annual revenue. In addition, he was involved in managing a number of mergers and acquisitions. Mr. Nunnelly has also served as an adjunct professor at the University of Massachusetts, School of Nursing, advising students and faculty on matters pertaining to healthcare information technology. These experiences and Mr. Nunnelly's expertise as a professional and educator in the field of healthcare information technology led to the conclusion that he should serve as a director of the Company.
高管简历
中英对照 | 中文 | 英文- Helen L. Hrdy
Helen L. Hrdy，自2020年1月起担任National Research Corporation首席增长官。在此之前，她从2012年1月到2020年1月担任National Research Corporation客户成功高级副总裁。在此之前，Hrdy女士自2000年以来在公司担任各种职务，并不断增加责任。
Helen L. Hrdy has served as Nrc Health's Chief Operating Officer since October 2024 and as an Executive Vice President since October 2025. Previously, Ms. Hrdy served as Nrc Health's Chief Customer Officer from January 2024 to October 2024, Nrc Health's Chief Growth Officer from January 2020 to January 2024, and Senior Vice President, Customer Success, from January 2012 to January 2020. Prior to this Ms. Hrdy held various positions of increasing responsibility with the Company since 2000.- Helen L. Hrdy，自2020年1月起担任National Research Corporation首席增长官。在此之前，她从2012年1月到2020年1月担任National Research Corporation客户成功高级副总裁。在此之前，Hrdy女士自2000年以来在公司担任各种职务，并不断增加责任。
- Helen L. Hrdy has served as Nrc Health's Chief Operating Officer since October 2024 and as an Executive Vice President since October 2025. Previously, Ms. Hrdy served as Nrc Health's Chief Customer Officer from January 2024 to October 2024, Nrc Health's Chief Growth Officer from January 2020 to January 2024, and Senior Vice President, Customer Success, from January 2012 to January 2020. Prior to this Ms. Hrdy held various positions of increasing responsibility with the Company since 2000.
- Andrew Monnich
Andrew Monnich，自2024年1月起担任首席企业发展官。过去20年，Monnich先生曾在医疗保健、金融服务和教育行业担任产品和企业开发职务，包括2011年至2013年担任公司高级副总裁–战略和企业发展，2013年至2016年担任Connect的董事总经理和联合创始人（当时Connect被公司收购），以及2018年7月至2020年8月担任Practicing Excellence的首席战略官。最近，Monnich先生担任顾问；制定、定义和实施战略，帮助企业对其创新和绩效进行持久改进。
Andrew Monnich,has served as Chief Corporate Development Officer since January 2024. For over the past 20 years, Mr. Monnich has worked in product and corporate development roles across the healthcare, financial services, and education industries, including for the Company as Senior Vice President – Strategy and Corporate Development from 2011 to 2013, as Managing Director and Co-Founder of Connect from 2013 to 2016, when Connect was acquired by the Company, and as Chief Strategy Officer at Practicing Excellence from July 2018 to August 2020. Most recently Mr. Monnich has worked as a consultant; developing, defining, and implementing strategies that help businesses make lasting improvements to their innovation and performance.- Andrew Monnich，自2024年1月起担任首席企业发展官。过去20年，Monnich先生曾在医疗保健、金融服务和教育行业担任产品和企业开发职务，包括2011年至2013年担任公司高级副总裁–战略和企业发展，2013年至2016年担任Connect的董事总经理和联合创始人（当时Connect被公司收购），以及2018年7月至2020年8月担任Practicing Excellence的首席战略官。最近，Monnich先生担任顾问；制定、定义和实施战略，帮助企业对其创新和绩效进行持久改进。
- Andrew Monnich,has served as Chief Corporate Development Officer since January 2024. For over the past 20 years, Mr. Monnich has worked in product and corporate development roles across the healthcare, financial services, and education industries, including for the Company as Senior Vice President – Strategy and Corporate Development from 2011 to 2013, as Managing Director and Co-Founder of Connect from 2013 to 2016, when Connect was acquired by the Company, and as Chief Strategy Officer at Practicing Excellence from July 2018 to August 2020. Most recently Mr. Monnich has worked as a consultant; developing, defining, and implementing strategies that help businesses make lasting improvements to their innovation and performance.
- Jordan N. Freeman
Jordan N. Freeman，于2025年4月加入公司，担任财务运营副总裁。在加入公司之前，Freeman女士曾在Nelnet, Inc.担任过各种职务，这是一家在纽约证券交易所上市的公司，业务涉及消费者贷款、贷款服务、支付和技术。2023年1月至2025年3月，Freeman女士担任会计-尼尔网业务解决方案总监，2019年1月至2023年1月担任会计-尼尔网 Diversified Solutions总监，2016年7月至2018年12月担任分部控制人–经理，尼尔网 Diversified Solutions。在尼尔网任职期间，Freeman女士负责监督尼尔网某些部门的会计操作。Freeman女士还曾于2015年至2016年担任HBE Becker Meyer Love，LLP的会计师，并于2011年至2015年担任Deloitte & Touche LLP的高级审计助理。弗里曼女士是一名注册会计师。
Jordan N. Freeman,joined the Company in April 2025 as Vice President, Finance Operations. Prior to joining the Company, Ms. Freeman served in various roles at Nelnet, Inc., a publicly traded company on the New York Stock Exchange with businesses related to consumer lending, loan servicing, payments, and technology. From January 2023 to March 2025, Ms. Freeman served as Director of Accounting - Nelnet Business Solutions, from January 2019 to January 2023, she served as Director of Accounting - Nelnet Diversified Solutions, and from July 2016 to December 2018, she served as Segment Controller – Manager, Nelnet Diversified Solutions. During her time at Nelnet, Ms. Freeman oversaw accounting operations for certain segments of Nelnet. Ms. Freeman also served as an Accountant for HBE Becker Meyer Love, LLP from 2015 to 2016 and as a Senior Audit Associate with Deloitte & Touche LLP from 2011 to 2015. Ms. Freeman is a Certified Public Accountant.- Jordan N. Freeman，于2025年4月加入公司，担任财务运营副总裁。在加入公司之前，Freeman女士曾在Nelnet, Inc.担任过各种职务，这是一家在纽约证券交易所上市的公司，业务涉及消费者贷款、贷款服务、支付和技术。2023年1月至2025年3月，Freeman女士担任会计-尼尔网业务解决方案总监，2019年1月至2023年1月担任会计-尼尔网 Diversified Solutions总监，2016年7月至2018年12月担任分部控制人–经理，尼尔网 Diversified Solutions。在尼尔网任职期间，Freeman女士负责监督尼尔网某些部门的会计操作。Freeman女士还曾于2015年至2016年担任HBE Becker Meyer Love，LLP的会计师，并于2011年至2015年担任Deloitte & Touche LLP的高级审计助理。弗里曼女士是一名注册会计师。
- Jordan N. Freeman,joined the Company in April 2025 as Vice President, Finance Operations. Prior to joining the Company, Ms. Freeman served in various roles at Nelnet, Inc., a publicly traded company on the New York Stock Exchange with businesses related to consumer lending, loan servicing, payments, and technology. From January 2023 to March 2025, Ms. Freeman served as Director of Accounting - Nelnet Business Solutions, from January 2019 to January 2023, she served as Director of Accounting - Nelnet Diversified Solutions, and from July 2016 to December 2018, she served as Segment Controller – Manager, Nelnet Diversified Solutions. During her time at Nelnet, Ms. Freeman oversaw accounting operations for certain segments of Nelnet. Ms. Freeman also served as an Accountant for HBE Becker Meyer Love, LLP from 2015 to 2016 and as a Senior Audit Associate with Deloitte & Touche LLP from 2011 to 2015. Ms. Freeman is a Certified Public Accountant.
- Shane Harrison
Shane Harrison自2025年9月起担任上市医疗保健体验公司NRC Health的执行副总裁兼首席财务官。在受雇于NRC健康公司之前，Harrison先生曾于2022年至2025年9月在K12教育软件的领先提供商PowerSchool担任财务和投资者关系高级副总裁；于2019年至2021年担任基于风险和合规的软件业务NAVEX Global的企业发展高级副总裁；并于2010年至2019年担任多个职位，包括公司发展和投资者关系高级副总裁、公司财务主管以及感知和意识技术的上市提供商菲利尔系统的临时首席财务官。哈里森先生的职业生涯始于德勤会计师事务所，在获得俄勒冈大学会计学理学学士学位和加州大学洛杉矶分校安德森管理学院工商管理硕士学位后，他成为雷曼兄弟公司的投资银行家。
Shane Harrison served as the Executive Vice President and Chief Financial Officer of NRC Health, a publicly traded healthcare experience company, since September 2025. Prior to his employment at NRC Health, Mr. Harrison served as Senior Vice President of Finance and Investor Relations at PowerSchool, a leading provider of K 12 education software, from 2022 to September 2025; Senior Vice President of Corporate Development for NAVEX Global, a risk and compliance based software business, from 2019 to 2021; and in various positions, including Senior Vice President of Corporate Development and Investor Relations, Corporate Treasurer, and Interim CFO, for FLIR Systems, a publicly traded provider of perception and awareness technologies, from 2010 to 2019. Mr. Harrison began his career as a CPA at Deloitte and was an investment banker at Lehman Brothers after he received his Bachelor of Science in Accounting from the University of Oregon and a Master of Business Administration from the UCLA Anderson School of Management.- Shane Harrison自2025年9月起担任上市医疗保健体验公司NRC Health的执行副总裁兼首席财务官。在受雇于NRC健康公司之前，Harrison先生曾于2022年至2025年9月在K12教育软件的领先提供商PowerSchool担任财务和投资者关系高级副总裁；于2019年至2021年担任基于风险和合规的软件业务NAVEX Global的企业发展高级副总裁；并于2010年至2019年担任多个职位，包括公司发展和投资者关系高级副总裁、公司财务主管以及感知和意识技术的上市提供商菲利尔系统的临时首席财务官。哈里森先生的职业生涯始于德勤会计师事务所，在获得俄勒冈大学会计学理学学士学位和加州大学洛杉矶分校安德森管理学院工商管理硕士学位后，他成为雷曼兄弟公司的投资银行家。
- Shane Harrison served as the Executive Vice President and Chief Financial Officer of NRC Health, a publicly traded healthcare experience company, since September 2025. Prior to his employment at NRC Health, Mr. Harrison served as Senior Vice President of Finance and Investor Relations at PowerSchool, a leading provider of K 12 education software, from 2022 to September 2025; Senior Vice President of Corporate Development for NAVEX Global, a risk and compliance based software business, from 2019 to 2021; and in various positions, including Senior Vice President of Corporate Development and Investor Relations, Corporate Treasurer, and Interim CFO, for FLIR Systems, a publicly traded provider of perception and awareness technologies, from 2010 to 2019. Mr. Harrison began his career as a CPA at Deloitte and was an investment banker at Lehman Brothers after he received his Bachelor of Science in Accounting from the University of Oregon and a Master of Business Administration from the UCLA Anderson School of Management.
- Trent Green
特伦特·格林自2025年6月起担任NRC Health的首席执行官。在加入公司之前，Green先生于2023年9月至2025年2月期间担任亚马逊旗下混合初级保健提供商Amazon One Medical的首席执行官，并于2022年7月至2023年8月期间担任Amazon One Medical的首席运营官。在加入Amazon One Medical之前，格林先生曾在非营利性医疗保健系统Legacy Health担任多个职务，包括2019年至2022年期间的高级副总裁兼首席运营官，2017年至2019年期间的伊曼纽尔医疗中心总裁，以及2008年至2017年期间的高级副总裁兼首席战略官。1999年至2008年，Green先生是Tiber Group/法维翰咨询（现为Guidehouse）的管理顾问。
Trent Green has served as Nrc Health's Chief Executive Officer since June 2025. Prior to joining the Company, Mr. Green served as Chief Executive Officer of Amazon One Medical, a hybrid primary care provider owned by Amazon, from September 2023 to February 2025 and as Chief Operating Officer of Amazon One Medical from July 2022 through August 2023. Prior to Amazon One Medical, Mr. Green served in various roles at Legacy Health, a nonprofit healthcare system, including Senior Vice President and Chief Operating Officer between 2019 and 2022, President, Emanuel Medical Center, between 2017 and 2019, and Senior Vice President and Chief Strategy Officer between 2008 and 2017. From 1999 to 2008, Mr. Green was a management consultant for Tiber Group/Navigant Consulting (now Guidehouse).- 特伦特·格林自2025年6月起担任NRC Health的首席执行官。在加入公司之前，Green先生于2023年9月至2025年2月期间担任亚马逊旗下混合初级保健提供商Amazon One Medical的首席执行官，并于2022年7月至2023年8月期间担任Amazon One Medical的首席运营官。在加入Amazon One Medical之前，格林先生曾在非营利性医疗保健系统Legacy Health担任多个职务，包括2019年至2022年期间的高级副总裁兼首席运营官，2017年至2019年期间的伊曼纽尔医疗中心总裁，以及2008年至2017年期间的高级副总裁兼首席战略官。1999年至2008年，Green先生是Tiber Group/法维翰咨询（现为Guidehouse）的管理顾问。
- Trent Green has served as Nrc Health's Chief Executive Officer since June 2025. Prior to joining the Company, Mr. Green served as Chief Executive Officer of Amazon One Medical, a hybrid primary care provider owned by Amazon, from September 2023 to February 2025 and as Chief Operating Officer of Amazon One Medical from July 2022 through August 2023. Prior to Amazon One Medical, Mr. Green served in various roles at Legacy Health, a nonprofit healthcare system, including Senior Vice President and Chief Operating Officer between 2019 and 2022, President, Emanuel Medical Center, between 2017 and 2019, and Senior Vice President and Chief Strategy Officer between 2008 and 2017. From 1999 to 2008, Mr. Green was a management consultant for Tiber Group/Navigant Consulting (now Guidehouse).
- David Burik
David Burik于2026年1月加入公司担任执行副总裁，Strategic Insights，带来30多年的医疗保健咨询经验。在加入公司之前，他曾于2020年1月至2026年1月担任Guidehouse的合伙人，Guidehouse是一家领先的咨询、技术和托管服务提供商，并于2004年1月至2020年1月担任Navigant的董事总经理。Burik先生于1989年至2004年担任Tiber Group的创始合伙人，并于1980年至1989年担任普华永道的经理。
David Burik joined the Company as Executive Vice President, Strategic Insights in January 2026, has more than 30 years of healthcare consulting experience. Prior to joining the Company, he was a Partner at Guidehouse, a leading provider of consulting, technology, and managed services, from January 2020 to January 2026 and served as Managing Director at Navigant from January 2004 to January 2020. Mr. Burik was a Founding Partner at Tiber Group from 1989 to 2004 and served as Manager at Price Waterhouse from 1980 to 1989.- David Burik于2026年1月加入公司担任执行副总裁，Strategic Insights，带来30多年的医疗保健咨询经验。在加入公司之前，他曾于2020年1月至2026年1月担任Guidehouse的合伙人，Guidehouse是一家领先的咨询、技术和托管服务提供商，并于2004年1月至2020年1月担任Navigant的董事总经理。Burik先生于1989年至2004年担任Tiber Group的创始合伙人，并于1980年至1989年担任普华永道的经理。
- David Burik joined the Company as Executive Vice President, Strategic Insights in January 2026, has more than 30 years of healthcare consulting experience. Prior to joining the Company, he was a Partner at Guidehouse, a leading provider of consulting, technology, and managed services, from January 2020 to January 2026 and served as Managing Director at Navigant from January 2004 to January 2020. Mr. Burik was a Founding Partner at Tiber Group from 1989 to 2004 and served as Manager at Price Waterhouse from 1980 to 1989.
- Jason R. Rau
Jason R. Rau自2025年10月起担任销售执行副总裁。他此前曾在公司担任过多个职务，包括1995年至2002年担任区域经理，2002年至2003年担任区域经理，2003年至2008年担任NRC Picker销售副总裁，2008年至2011年担任NRC Picker总裁，2011年至2013年担任战略与企业发展部门总裁，并于2024年7月至2025年10月担任高级副总裁。Rau先生还曾于2022年6月至2024年7月（Nobl被公司收购）期间，担任Nobl（一家医疗保健舍入技术公司）的首席增长官，并于2018年1月至2022年6月担任Practicing Excellence（一家专注于医疗保健的人类发展公司）的业务发展执行副总裁。他也是2013年至2016年Connect的联合创始人。Rau先生于2009年至2010年在联合委员会的专家顾问小组任职，并于1993年至1995年开始了他在电信行业的客户经理的职业生涯。
Jason R. Rau has served as Executive Vice President, Sales since October 2025. He previously served in various roles at the Company, including as Area Manager from 1995 to 2002, as Regional Manager from 2002 to 2003, Vice President of Sales of NRC Picker from 2003 to 2008, President of NRC Picker from 2008 to 2011, in Strategy and Corporate Development from 2011 to 2013, and as Senior Vice President from July 2024 to October 2025. Mr. Rau also served as Chief Growth Officer of Nobl, a healthcare rounding technology company, from June 2022 to July 2024 when Nobl was acquired by the Company, and as Executive Vice President Business Development of Practicing Excellence, a human development company specializing in healthcare, from January 2018 to June 2022. He was also the Co Founder of Connect from 2013 to 2016. Mr. Rau served on an Expert Advisor Panel at The Joint Commission from 2009 to 2010 and began his career as an Account Executive in the telecom industry from 1993 to 1995.- Jason R. Rau自2025年10月起担任销售执行副总裁。他此前曾在公司担任过多个职务，包括1995年至2002年担任区域经理，2002年至2003年担任区域经理，2003年至2008年担任NRC Picker销售副总裁，2008年至2011年担任NRC Picker总裁，2011年至2013年担任战略与企业发展部门总裁，并于2024年7月至2025年10月担任高级副总裁。Rau先生还曾于2022年6月至2024年7月（Nobl被公司收购）期间，担任Nobl（一家医疗保健舍入技术公司）的首席增长官，并于2018年1月至2022年6月担任Practicing Excellence（一家专注于医疗保健的人类发展公司）的业务发展执行副总裁。他也是2013年至2016年Connect的联合创始人。Rau先生于2009年至2010年在联合委员会的专家顾问小组任职，并于1993年至1995年开始了他在电信行业的客户经理的职业生涯。
- Jason R. Rau has served as Executive Vice President, Sales since October 2025. He previously served in various roles at the Company, including as Area Manager from 1995 to 2002, as Regional Manager from 2002 to 2003, Vice President of Sales of NRC Picker from 2003 to 2008, President of NRC Picker from 2008 to 2011, in Strategy and Corporate Development from 2011 to 2013, and as Senior Vice President from July 2024 to October 2025. Mr. Rau also served as Chief Growth Officer of Nobl, a healthcare rounding technology company, from June 2022 to July 2024 when Nobl was acquired by the Company, and as Executive Vice President Business Development of Practicing Excellence, a human development company specializing in healthcare, from January 2018 to June 2022. He was also the Co Founder of Connect from 2013 to 2016. Mr. Rau served on an Expert Advisor Panel at The Joint Commission from 2009 to 2010 and began his career as an Account Executive in the telecom industry from 1993 to 1995.